- Application for recombinant Insulin Human AF
- Front Page
- Onboarding of new employees
- Registrant group for Cetrimonium Bromide (CTAB)
- Registrant group for Reaction mass of C12 trimethylammonium bromide and C14 trimethylammonium bromide
- Registrant group for Tetradonium Bromide
- Applications for Quats
- Why us
- Download & Publications
- Contact us
Introduction of Pierre De Meyts. MD, PHD, F.A.C.E.
Pierre de Meyts is an expert who has worked with and researched insulin and receptor binding for almost half a century. Novo Nordisk Pharmatech A/S is proud to present what we assume to be one of the best homepages describing the functionality of insulin and insulin like growth factors with respect to receptor binding and cellular response.
More details regarding Pierre de Meyts can be found at
Introduction of Francesc Gòdia Casablancas, Professor of Chemical Engineering at Universitat Autònoma de Barcelona (Spain)
PhD from UAB in 1986. Post-doc in Oak Ridge National Laboratory (USA) in 1987. Full Professor at UAB since 1993. Research activity on Biotechnology, Bioprocess Development, Bioreactor Design, Animal Cell Technology, Metabolic Engineering and Life Support in Space. Overall Manager of the MELiSSA Pilot Plant of the European Space Agency. Teaching activity in Chemical Engineering and Biotechnology. Coordinator of the ESACT Course on Animal Cell Technology. Author of more than 80 papers, 5 patents and advisor of 25 PhD thesis. Former President of the Spanish Society of Biotechnology. Former Vice-Rector of UAB. Member of the Executive Board of the European Society of Biotechnology and the Executive Committee of the European Society of Animal Cell Technology. Chair of several international congresses.
Introduction of Karina S. Kristensen, M.Sc.in Cell Biology, Novo Nordisk Pharmatech A/S
Karina S. Kristensen has researched in the field of reproductive biology and cancer diagnostics.
Previously to FeF Chemicals she worked as Process Supporter at a Novo Nordisk insulin purification plant.